Use of Study Results. Subject to Applicable Law, Sponsor shall have the unrestricted right to use and publish, any data and information from the Study without the consent of Investigator or Institution, provided that Sponsor maintains subject confidentiality. The Site will not use data generated during the Study or results of the Study for any purpose other than care of a subject, for internal research purposes, or for publication subject to Article 9, below. For the avoidance of doubt, internal research purposes means internal, non- commercial research activities that are not funded by a third party (other than a government agency). The Site shall obtain all legally required authorizations or other documentation from Study subjects to allow for disclosures of Study subjects’ data to Sponsor and its Designee in accordance with this Agreement. 8. Použití výsledků klinického hodnocení. V souladu s příslušnými předpisy bude mít zadavatel neomezené právo používat a publikovat veškeré údaje a informace z klinického hodnocení bez souhlasu hlavního zkoušejícího a zdravotnického zařízení za podmínky, xx xxxxxxx důvěrnost informací subjektů klinického hodnocení. Řešitelské centrum nebude používat údaje vytvořené během klinického hodnocení ani výsledky klinického hodnocení za jiným účelem něž při péči o subjekt, pro účely interního výzkumu a publikování v souladu s čl. 9 níže. Pro vyloučení všech pochybností se uvádí, že účely interního výzkumu se rozumí interní, nekomerční výzkumné činnosti, které nejsou financovány třetí stranou (s výjimkou státních úřadů). Řešitelské centrum od subjektů klinického hodnocení xxxxx veškerá zákonem požadovaná oprávnění a další dokumenty, které umožňují poskytnout údaje subjektů klinického hodnocení zadavateli a xxxx xxxxxxxx osobě v souladu s touto smlouvou.
Use of Study Results. The Site shall maintain the security of Study subject data and shall obtain all authorizations or other necessary documentation from Study subjects to allow disclosures of Study subjects’ data to Sponsor and its agents and contractors, and, if this is a multi-site Study, with researchers at other Study sites, to the extent necessary for them to comply with this Agreement, the Privacy Regulations, and other Applicable Law, and for purposes related to the Study (including, without limitation, Study monitoring, analysis of Study data, and preparing applications and other reports to be submitted to regulatory authorities). The Institution and the Investigator agree to transfer to Sponsor only those data, including but not limited to clinical data regarding patients, which are made anonymous. This means that the data could be transferred by the Sponsor to any country in the world for processing including countries which do not have data protection laws as strict as those znamená, že údaje mohou být předávány Zadavatelem ke zpracování do jakékoli země na světě včetně zemí, které nemají tak přísné zákony o ochraně osobních údajů jako ty, které platí v Evropské unii (zejména Spojené státy americké). in force in the European Union (including, without limitation, the United States of America).
Use of Study Results. The Site shall maintain the security of Study subject data and shall obtain all authorizations or other necessary documentation from Study subjects to allow disclosures of Study subjects’ data to Sponsor and its agents and contractors, and, if this is a multi-site Study, with researchers at other Study sites, to the extent necessary for them to comply with this Agreement, the Privacy Regulations, and other Applicable Law, and for purposes related to the Study (including, without limitation, Study monitoring, analysis of Study data, and preparing applications and other reports to be submitted to regulatory authorities). The Institution and the Investigator agree to transfer to Sponsor only those data, including but not limited to clinical data regarding patients, which are made anonymous. This means that the data could be transferred by the Sponsor to any country in the world for processing including countries which do not have data protection laws as strict as those in force in the European Union (including, without limitation, the United States of America).
Use of Study Results. The Institution acknowledges that Sponsor may elect to use the results of the Study for the purposes of national and international registration, publication, and information for medical and pharmaceutical professionals. If necessary, the relevant regulatory and health authorities will be notified of the Principal Investigators’ name, address, qualifications and extent of involvement in the Study.
8.1 Využití Výsledků klinického hodnocení. Místo klinického hodnocení bere na vědomí, že Zadavatel se může rozhodnout použít výsledky Klinického hodnocení pro účely národní a mezinárodní registrace, zveřejnění a informací pro lékařské a farmaceutické odborníky. V případě potřeby budou příslušným regulačním a zdravotním orgánům oznámeny jméno, adresa, kvalifikace a rozsah účasti Hlavního zkoušejícího v Klinickém hodnocení.
Use of Study Results. 29Sponsor is committed to communicate product, research and development information in an accurate and objective manner. These communication activities must be undertaken in a responsible and ethical manner, taking into account relevant external standards regarding the manner and content of scientific, technical and medical publications. Sponsor fully supports the need for all authors of publications (both Sponsor’s employees and external collaborators) to disclose any potential conflicts of interest including any financial or personal relationships that might be perceived to bias their work.
Use of Study Results. Sponsor shall have the right to use all information resulting from the Study for any and all lawful purposes, subject to Section 9.2. Institution and Investigator shall have the right to use any information, data or results relating to the Study for non-commercial internal research purposes and patient care, and/or in a publication subject to Article 6.
Use of Study Results. Notwithstanding anything contained herein to the contrary, CFFT shall be entitled to use the Study results as they relate to Study design, choice of endpoints and placebo group data in furtherance of its charitable and educational purposes including sharing such Study results with other commercial entities (subject to appropriate confidentiality obligations); provided however that CFFT may not publish the Study results or other information relating to the Study without H-E’s prior written consent and may not use treatment group data in whole or part for any purpose and may not commercially benefit from any such sharing
Use of Study Results. Healthcare provider and Investigator acknowledge, that Sponsor is the exclusive owner of all Study Results and has the right to use the Study Results in any manner it deems appropriate, both during, and following termination of, this Agreement. Where Healthcare provider and/or Investigator require the use of the Study Results for publication, Healthcare provider and/or Investigator shall seek the Sponsor’s written approval which shall not be unreasonably withheld. The Study shall be registered at xxx.xxxxxxxxxxxxxx.xxx in a manner compliant with Law. 8.
1. Využití výsledků studie. Poskytovatel zdravotních služeb a zkoušející berou na vědomí, že zadavatel je výhradním vlastníkem veškerých výsledků studie a má právo použít výsledky studie jakýmkoli způsobem, který bude považovat za vhodný, a to jak během platnosti této smlouvy, tak i po jejím ukončení. Jestliže budou poskytovatel zdravotních služeb nebo zkoušející požadovat, aby byly výsledky klinického hodnocení využity k publikaci, poskytovatel zdravotních služeb nebo zkoušející požádají o písemný souhlas zadavatele a tento souhlas nebude bezdůvodně zdržován. Studie bude registrována na webu xxx.xxxxxxxxxxxxxx.xxx v souladu se zákony.
Use of Study Results. The Study results will belong to RECIPIENT. However, in consideration of PROVIDER’s contribution, PROVIDER shall be free to use the Study results contained in the final report for its own research purposes.
Use of Study Results. All data and information generated by Institution as a result of conducting the Study in accordance with the Protocol (“Study Results”) shall be the property of Sponsor. Study Results does not include original Study subject or patient medical records, research notebooks, source documents, or other routine internal documents kept in the Institution’s ordinary course of business operations, which shall remain the sole and exclusive property of the Institution or medical provider. Sponsor shall own and have the right to use the Study Results in accordance with the signed informed consent and authorization form, applicable laws, and the terms of this Agreement. Notwithstanding any licenses or other rights granted to Sponsor herein, but in accordance with the confidentiality and publication sections herein, Institution shall retain the right to use the Study Results and results for its publication, IRB, regulatory, legal, clinical, educational, and internal research purposes.
